AI assistant boosts eye doctor accuracy in retinal disease diagnosis?

NCT ID NCT07318428

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tested whether an AI tool can help eye doctors diagnose four common retinal diseases (diabetic retinopathy, age-related macular degeneration, retinal vein occlusion, and glaucoma) more accurately and quickly. Ten doctors from five hospitals read fundus images both with and without AI assistance. The goal was to see if the AI improves diagnostic sensitivity, specificity, and reading time.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
VUNO Med-Fundus AI (AI-based fundus image interpretation software)
What this could lead to
If successful, this could show that AI helps eye doctors diagnose common retinal diseases more accurately and quickly, potentially improving routine eye care.
What could go wrong
This is a small, early-stage study with only 10 readers, so results may not apply broadly. The AI only provides findings, not diagnoses, so its real-world benefit is still uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dong-A University Hospital

    Busan, 49201, South Korea

  • Inje University Busan Paik Hospital

    Busan, 47392, South Korea

  • Kosin University Gospel Hospital

    Busan, 49267, South Korea

  • Pusan National University Hospital

    Busan, 49241, South Korea

  • Pusan National University Yangsan Hospital

    Yangsan, 50612, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.